
Professor Takeshi Kimura
Hirakata Kohsai Hospital, Hirakata (Japan)
Membership:
FESC Member
Follow
Contributor content
Presentation
Stent type and duration of dual antiplatelet therapy.
Presentation
Optimal antithrombotic treatment beyond the first year post PCI for ACS
Presentation
Imaging for bioresorbable scaffolds - An Asian perspective
Presentation
ABSORB Japan: 2-year clinical results from a randomized trial evaluating the Absorb Bioresorbable Vascular Scaffold vs. metallic drug-eluting stent in de novo native coronary artery lesions
Presentation

